Abstract
Series of ring-substituted 3-hydroxynaphthalene-2-carboxanilides were screened for their in vitro activity against wild-type S427 (bloodstream form) of Trypanosoma brucei brucei. 3-Hydroxy-N-(3-trifluoromethylphenyl)- and 3-hydroxy-N-(4-trifluoromethylphenyl)naphthalene-2-carboxamides showed the highest biological activity (MIC = 1.56 and 2.08 µmol/dm3, respectively). Antitrypanosomal activity was correlated with the experimentally determined lipophilicity and acid–base dissociation constants of the compounds as well as with the calculated electronic properties of individual anilide substituents expressed as Hammett’s σ parameters. The substitution in the meta- or para-position of anilide of derivatives with higher lipophilicity by an electron-withdrawing moiety is favourable for higher activity. The optimum thermodynamic pK Ta value was found to be ca. 7.5. The structure–activity relationships of all compounds are discussed.
Graphical abstract
Similar content being viewed by others
References
WHO (2017) Trypanosomiasis, human African (sleeping sickness). Fact sheets. http://www.who.int/mediacentre/factsheets/fs259/en/. Accessed 3 Nov
Steinhilber D, Schubert-Zsilavecz M, Roth HJ (2010) Antiprotozoische Wirkstoffe. In: Medizinische Chemie: Targets, Arzneistoffe, Chemische Biologie. Deutscher Apotheker Verlag, Stutgart, p 586
Jampilek J (2014) Curr Med Chem 21:4347
Cullen DR, Mocerino M (2017) Curr Med Chem 24:701
Kos J, Zadrazilova I, Pesko M, Keltosova S, Tengler J, Gonec T, Bobal P, Kauerova T, Oravec M, Kollar P, Cizek A, Kralova K, Jampilek J (2013) Molecules 18:7977
Gonec T, Zadrazilova I, Nevin E, Kauerova T, Pesko M, Kos J, Oravec M, Kollar P, Coffey A, O’Mahony J, Cizek A, Kralova K, Jampilek J (2015) Molecules 20:9767
Asif M (2016) Mod Chem Appl 4:194
Jampilek J, Brychtova K (2012) Med Res Rev 32:907
Gonec T, Bobal P, Sujan J, Pesko M, Guo J, Kralova K, Pavlacka L, Vesely L, Kreckova E, Kos J, Coffey A, Kollar P, Imramovsky A, Placek L, Jampilek J (2012) Molecules 17:613
Gonec T, Kos J, Nevin E, Govender R, Pesko M, Tengler J, Kushkevych I, Stastna V, Oravec M, Kollar P, O’Mahony J, Kralova K, Coffey A, Jampilek J (2014) Molecules 19:10386
Gonec T, Kos J, Zadrazilova I, Pesko M, Govender R, Keltosova S, Chambel B, Pereira D, Kollar P, Imramovsky A, O’Mahony J, Coffey A, Cizek A, Kralova K, Jampilek J (2013) Molecules 18:9397
Gonec T, Kos J, Zadrazilova I, Pesko M, Keltosova S, Tengler J, Bobal P, Kollar P, Cizek A, Kralova K, Jampilek J (2013) Bioorg Med Chem 21:6531
Gonec T, Pospisilova S, Holanova L, Stranik J, Cernikova A, Pudelkova V, Kos J, Oravec M, Kollar P, Cizek A, Jampilek J (2016) Molecules 21:1189
Kos J, Nevin E, Soral M, Kushkevych I, Gonec T, Bobal P, Kollar P, Coffey A, O’Mahony J, Liptaj T, Kralova K, Jampilek J (2015) Bioorg Med Chem 23:2035
Kratky M, Vinsova J (2011) Curr Pharm Des 17:3494
Zadrazilova I, Pospisilova S, Masarikova M, Imramovsky A, Monreal-Ferriz J, Vinsova J, Cizek A, Jampilek J (2015) Eur J Pharm Sci 77:197
Pattabiraman VR, Bode JW (2011) Nature 480:471
Ferrins L, Gazdik M, Rahmani R, Varghese S, Sykes ML, Jones AJ, Avery VM, White KL, Ryan E, Charman SA, Kaiser M, Bergström CA, Baell JB (2014) J Med Chem 57:6393
Russell S, Rahmani R, Jones AJ, Newson HL, Neilde K, Cotillo I, Rahmani Khajouei M, Ferrins L, Qureishi S, Nguyen N, Martinez-Martinez MS, Weaver DF, Kaiser M, Riley J, Thomas J, De Rycker M, Read KD, Flematti GR, Ryan E, Tanghe S, Rodriguez A, Charman SA, Kessler A, Avery VM, Baell JB, Piggott MJ (2016) J Med Chem 59:9686
Masand VH, El-Sayed NNE, Mahajan DT, Rastija V (2017) Environ Res 28:165
Jacobs RT, Nare B, Phillips MA (2011) Curr Top Med Chem 11:1255
Testa B, van de Waterbeemd H, Folkers G, Guy R (2001) Pharmacokinetic optimization in drug research. Wiley, Weinheim
Babic S, Horvat AJM, Mutavdzic Pavlovic D, Kastelan-Macan M (2007) Trends Anal Chem 26:1043
Fuguet E, Reta M, Gibert C, Roses M, Bosch E, Rafols C (2008) Electrophoresis 29:2841
Slampova A, Krivankova L, Gebauer P, Bocek PJ (2008) J Chromatogr A 1213:25
Jampilek J, Clements C, Kos J, Gonec T, Gray AI (2014) Book of abstracts: the 6th conversatory on medicinal chemistry, Lublin, Poland, Sept 18–20, p 24 (K5)
Kauerova T, Kos J, Gonec T, Jampilek J, Kollar P (2016) Int J Mol Sci 17:1219
Robinson D (2017) Buffer calculator. http://dbr.csoft.net/chem/bufcalc.php. Accessed 30 Sept
Poole SK, Patel S, Dehring K, Workman H, Poole CF (2014) J Chromatogr A 1037:445
Ornskov E, Linusson A, Folestad S (2003) J Pharm Biomed Anal 33:379
Raz B, Iten M, Grether-Buhler Y, Kaminsky R, Brun R (1997) Acta Trop 68:139
Spencer J, Rathnam RP, Harvey AL, Clements CJ, Clark RL, Barrett MP, Wong PE, Male L, Coles SJ, MacKay SP (2011) Bioorg Med Chem 19:1802
Lang S, Khalaf AI, Breen D, Huggan JK, Clements CJ, MacKay SP, Suckling CJ (2014) Med Chem Res 23:1170
Acknowledgements
This study was supported by Grants FaF UK/13/2016 and FaF UK/4/2017 and by sanofi-aventis Pharma Slovakia.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Kos, J., Kapustikova, I., Clements, C. et al. 3-Hydroxynaphthalene-2-carboxanilides and their antitrypanosomal activity. Monatsh Chem 149, 887–892 (2018). https://doi.org/10.1007/s00706-017-2099-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-017-2099-1